Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health
Publication date
2023-06
Authors
Hermans, Mireille M
Pasmans, Suzanne G M A
de Laat, Peter C J
Slieker, Martijn G
Mendels, Elodie J
de Graaf, M
Langeveld, Hester R
Schappin, Renske
Rietman, André B
Breugem, C.C.
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Keywords
adrenergic beta-antagonists, blood pressure, capillary hemangioma, child, growth and development, infant, long-term adverse effects, vascular malformations, vascular tissue neoplasms, Dermatology
Citation
Hermans, M M, Pasmans, S G M A, de Laat, P C J, Slieker, M G, Mendels, E J, de Graaf, M, Langeveld, H R, Schappin, R, Rietman, A B, Breugem, C C, Breur, J M P J, de Wildt, S N & Raphael, M F 2023, 'Propranolol or atenolol for the management of infantile hemangioma : Implications for long-term health', JAAD international, vol. 11, pp. 137-139. https://doi.org/10.1016/j.jdin.2023.02.001